Oxular Limited
Private Limited Company · Uxbridge
ActiveUnited KingdomIncorporated 2014Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 136 source facts · 18 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 136 source facts · 18 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-11-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 81
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod223_4319_09331313_20251231
- Source archive
- Accounts_Bulk_Data-2026-10-01.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-10-31
IXBRL · 206 source facts · 11 selected values
Not assessedlegacy record
Accounts to 2023-10-31
IXBRL · 206 source facts · 11 selected values
Not assessed
legacy record
- Reporting period
- 2022-11-01 to 2023-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 116
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- IFRS-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_1766_09331313_20231031
- Source archive
- Accounts_Monthly_Data-February2024.zip
Accounts to 2021-10-31
IXBRL · 165 source facts · 11 selected values
Not assessedlegacy record
Accounts to 2021-10-31
IXBRL · 165 source facts · 11 selected values
Not assessed
legacy record
- Reporting period
- 2020-11-01 to 2021-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 90
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- IFRS-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0105_09331313_20211031
- Source archive
- Accounts_Monthly_Data-April2022.zip
Accounts to 2020-10-31
IXBRL · 172 source facts · 11 selected values
Not assessedlegacy record
Accounts to 2020-10-31
IXBRL · 172 source facts · 11 selected values
Not assessed
legacy record
- Reporting period
- 2019-11-01 to 2020-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 88
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- IFRS-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0092_09331313_20201031
- Source archive
- Accounts_Monthly_Data-July2021.zip
Registered details
09331313- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2014-11-27
- Jurisdiction
- —
- Registered office
- THE CHARTER BUILDING, VINE STREET, UXBRIDGE, MIDDLESEX, UB8 1JG, ENGLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2024-12-20
£8,815,441 raised
£14,871,267 estimated post-money
2022-11-01
£8,999,103 raised
£67,296,740 estimated post-money
Research and innovation
4 matched grantsNovel Treatment of RetinoblastomaLead
Innovate UK · Collaborative R&D · 2021-12-01 – 2022-01-31
£99,750
awarded
Novel Treatment of RetinoblastomaLead
Innovate UK · Collaborative R&D · 2019-07-01 – 2023-09-30
£1,992,385
awarded
Novel Treatments of Uveal MelanomaLead
Innovate UK · Feasibility Studies · 2018-03-01 – 2019-04-30
£128,867
awarded
Novel Treatment of Retinal Oncology DiseasesLead
Innovate UK · Collaborative R&D · 2017-01-01 – 2018-12-31
£690,003
awarded